The demand for clarity from National Institutes of Health Director Dr. Jayanta “Jay” Bhattacharya comes on the heels of a contentious Capitol Hill appearance in February.

The pseudomonal infections clinical trial analysis report delivers important insights into ongoing research of 10+ pipeline ...

In a phase 2b clinical trial, an investigational oral therapy called PrimeC was found to be safe and well tolerated in people ...

One mother told Newsweek she was "terrified" of losing access to the drug her daughter relies on as a result of an FDA ...

YOLT-202 is currently under investigation in a trial assessing tolerability YolTech Therapeutics has received clearance from ...

MRT-2359 is an investigational, orally bioavailable, GSPT1-directed molecular glue degrader that has shown compelling clinical activity in combination with androgen receptor (AR) inhibition in heavily ...

Deciding if and when to pursue deep brain stimulation (DBS) can be overwhelming for people with Parkinson's disease. While ...

A new clinical study suggests that successful root canal treatment may benefit more than just dental health. Patients treated ...

Dr. Tara Gregory says women remain underrepresented in studies and encourages participation in clinical trials and consultation with trusted medical providers.

Alessa Therapeutics ("Alessa"), a clinical-stage biopharmaceutical company advancing novel localized drug delivery technology ...

LTR Pharma recently announced the dosing of the first patients in the Phase II study of SPONTAN ®, which is evaluating the ...

CLEVELAND, Ohio — A shift toward personalized treatment for breast cancer, ways to help patients live longer without their ...